Curate Biosciences Announces David Backer as Chief Executive Officer

Former Oxford Biomedica CCO to bring extensive cell and gene therapy commercialization expertise CARLSBAD, Calif., Dec. 16, 2022 /PRNewswire/ — Curate Biosciences, a key enabling technology company for cell therapy manufacturing, today announced that David M. Backer will become the…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks